2025 Performance Review And Future Strategy
Source: SeekingAlpha
2025-12-22 08:30:48 ET
Now that 2025 is nearing its close and the holidays are upon us, I want to wish readers a joyous year-end holiday season. You likely have festivities to attend (and I do too), but as the year winds down I wanted to close with my annual performance review. Business before pleasure, right? So let's get down to it, how did my stock picks fare in 2025? Am I due for presents under the tree this year, or just a lump of coal?...
Read the full article on Seeking Alpha
For further details see:
2025 Performance Review And Future Strategy
Rigel Pharmaceuticals Inc.
NASDAQ: RIGL
RIGL Trading
-3.13% G/L:
$26.0825 Last:
96,605 Volume:
$26.87 Open:
RIGL Latest News
March 03, 2026 04:01:00 pm
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
RIGL Stock Data
$625,132,287
16,430,597
0.07%
54
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
